Author:
Aggarwal A.,Fojo T.,Chamberlain C.,Davis C.,Sullivan R.
Reference102 articles.
1. Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care[quest];Davies;Br J Cancer,2012
2. House of Commons Committee of Public Accounts. Cancer Drugs Fund—20th Report. House of Commons, 2016.
3. NHS England Clinical Effectiveness Team. NHS England Consultation: Proposals for a Sustainable Cancer Drug Fund. NHS England, 2014.
4. NHS England. National Cancer Drugs Fund List. 2015.
5. 753O final overall survival (OS) analysis of COU-AA-302, a randomized phase 3 study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (MCRPC) patients (PTS) without prior chemotherapy;Ryan;Ann Oncol,2014
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献